Related Experiment Video

Updated: Jul 24, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Mechanisms of Efficacy: Safety Concerns and Early Results

Bashir1, Vale, Isner

  • 1Department of Cardiovascular Medicine and Research, St. Elizabeth's Medical Center, 736 Cambridge Street, Boston, MA 02135, USA. dlosordo@opal.tufts.edu

Current Interventional Cardiology Reports
|November 30, 2000
PubMed

Insights

Therapeutic angiogenesis aims to stimulate new blood vessel growth for patients with peripheral and myocardial ischemia who cannot undergo traditional revascularization. This approach addresses the clinical need for improved treatments in hypovascular conditions.

Area of Science:

  • Cardiovascular Medicine
  • Regenerative Medicine
  • Vascular Biology

Background:

  • Coronary and peripheral atherosclerotic diseases impact millions, with existing therapies not suitable for all patients.
  • A significant patient group remains symptomatic and at high risk for adverse events like limb loss or death.
  • Advances in understanding angiogenesis have opened new therapeutic avenues.

Purpose of the Study:

  • To explore therapeutic angiogenesis as a treatment for peripheral and myocardial ischemia.
  • To address the unmet clinical need in patients unsuitable for conventional revascularization.
  • To focus on stimulating neovascularization in hypovascular conditions.

Main Methods:

  • Investigating the potential of stimulating new blood vessel formation (neovascularization).
  • Focusing on therapeutic strategies for local hypovascularity.
  • Leveraging advances in the understanding of angiogenesis.

Main Results:

  • Therapeutic angiogenesis is being developed to treat ischemia.
  • Neovascularization is a key focus for treating hypovascular diseases.
  • This approach targets patients with limited revascularization options.

Conclusions:

  • Therapeutic angiogenesis offers a promising strategy for ischemic diseases.
  • Stimulating neovascularization addresses critical needs in cardiovascular medicine.
  • This field holds potential for patients with limited treatment options.

More Related Videos

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development07:02

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

Related Concept Videos

Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it produces...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).